Associated response in bone mineral density and atherogenic lipid profile during treatment with two different selective estrogen receptor modulators: levormeloxifene and raloxifene (Q42166397)

From Wikidata

Jump to navigation Jump to search

scientific article published on June 2003

Language	Label	Description	Also known as
English	Associated response in bone mineral density and atherogenic lipid profile during treatment with two different selective estrogen receptor modulators: levormeloxifene and raloxifene	scientific article published on June 2003

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Associated response in bone mineral density and atherogenic lipid profile during treatment with two different selective estrogen receptor modulators: levormeloxifene and raloxifene (English)

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

atherosclerosis

1 reference

based on heuristic

inferred from title

author name string

A Bloch-Thomsen

1

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

S Silvestri

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

C Christiansen

3

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

N H Bjarnason

4

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

publication date

1 June 2003

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

6

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

2

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

159-167

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Long-term prevention of postmenopausal osteoporosis by oestrogen. Evidence for an increased bone mass after delayed onset of oestrogen treatment

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Effects of tamoxifen on bone mineral density in postmenopausal women with breast cancer

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Five versus more than five years of tamoxifen for lymph node-negative breast cancer: updated findings from the National Surgical Adjuvant Breast and Bowel Project B-14 randomized trial

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Raloxifene (LY139481 HCI) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Long-term effects of raloxifene on bone mineral density, bone turnover, and serum lipid levels in early postmenopausal women: three-year data from 2 double-blind, randomized, placebo-controlled trials

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Prevention of bone loss with alendronate in postmenopausal women under 60 years of age. Early Postmenopausal Intervention Cohort Study Group.

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial. Multiple Outcomes of Raloxifene Evaluation (MORE) Investigators

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Design and methods of the Raloxifene Use for The Heart (RUTH) study

1 reference

https://api.crossref.org/works/10.1080%2FCMT.6.2.159.167

21 January 2018

Identifiers

10.1080/CMT.6.2.159.167

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

17 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42166397&oldid=2117514463"